KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Resmed (RMD) over the last 9 years, with Q4 2025 value amounting to $5.9 million.

  • Resmed's Restructuring Costs changed N/A to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.8 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2025, which is 9683.78% down from last year.
  • Latest data reveals that Resmed reported Restructuring Costs of $5.9 million as of Q4 2025.
  • Resmed's 5-year Restructuring Costs high stood at $64.2 million for Q4 2023, and its period low was $1.8 million during Q2 2023.
  • In the last 3 years, Resmed's Restructuring Costs had a median value of $5.9 million in 2025 and averaged $14.3 million.
  • The largest annual percentage gain for Resmed's Restructuring Costs in the last 5 years was 66352.83% (2023), contrasted with its biggest fall of 568.42% (2023).
  • Resmed's Restructuring Costs (Quarter) stood at $8.4 million in 2022, then skyrocketed by 663.53% to $64.2 million in 2023, then crashed by 90.76% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q4 2025, $15.8 million for Q3 2025, and $2.0 million during Q2 2025.